Search

everythinglearnresearchcommunity

for

Search:↓

The health of the sentinel lymph node is the best indicator of survival for patients with thick skin cancer.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

The cat died from a hard-to-treat fungal infection despite various treatments.

Face transplant for a severe autoimmune disease patient was successful, improving appearance and function without disease relapse after three years.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

Balneophototherapy effectively treats ichthyosis linearis circumflexa but may need ongoing treatment due to short remission.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Higher antigliadin antibody levels are linked to alopecia areata severity.

A young woman with late-stage Vogt-Koyanagi-Harada disease was successfully treated at a hospital.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.